NYSE:HCP - HCP Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $29.87 -0.36 (-1.19 %) (As of 12/9/2018 04:00 PM ET)Previous Close$29.87Today's Range$29.68 - $30.1452-Week Range$21.48 - $30.26Volume3.38 million shsAverage Volume3.61 million shsMarket Capitalization$14.04 billionP/E Ratio15.32Dividend Yield4.95%Beta0.23 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index. Receive HCP News and Ratings via Email Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustrySpecialized REITs SectorFinance Current SymbolNYSE:HCP Previous Symbol CUSIP40414L10 Webwww.hcpi.com Phone949-407-0700 Debt Debt-to-Equity Ratio1.21 Current Ratio0.48 Quick Ratio0.48 Price-To-Earnings Trailing P/E Ratio15.32 Forward P/E Ratio16.41 P/E Growth7.53 Sales & Book Value Annual Sales$1.85 billion Price / Sales7.59 Cash Flow$2.0815 per share Price / Cash Flow14.35 Book Value$11.93 per share Price / Book2.50 Profitability EPS (Most Recent Fiscal Year)$1.95 Net Income$414.16 million Net Margins9.16% Return on Equity3.06% Return on Assets1.24% Miscellaneous Employees190 Outstanding Shares469,920,000Market Cap$14.04 billion OptionableOptionable HCP (NYSE:HCP) Frequently Asked Questions What is HCP's stock symbol? HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP." How often does HCP pay dividends? What is the dividend yield for HCP? HCP announced a quarterly dividend on Thursday, October 25th. Investors of record on Monday, November 5th will be given a dividend of $0.37 per share on Tuesday, November 20th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.95%. The ex-dividend date of this dividend is Friday, November 2nd. View HCP's Dividend History. How were HCP's earnings last quarter? HCP, Inc. (NYSE:HCP) issued its earnings results on Wednesday, October, 31st. The real estate investment trust reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.11 by $0.10. The real estate investment trust had revenue of $456 million for the quarter, compared to analyst estimates of $456.59 million. HCP had a net margin of 9.16% and a return on equity of 3.06%. The business's revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the business earned $0.48 earnings per share. View HCP's Earnings History. When is HCP's next earnings date? HCP is scheduled to release their next quarterly earnings announcement on Tuesday, February 12th 2019. View Earnings Estimates for HCP. What guidance has HCP issued on next quarter's earnings? HCP issued an update on its FY18 earnings guidance on Wednesday, October, 31st. The company provided earnings per share guidance of $1.79-1.83 for the period, compared to the Thomson Reuters consensus estimate of $1.82. What price target have analysts set for HCP? 15 brokerages have issued twelve-month price targets for HCP's stock. Their predictions range from $21.00 to $30.00. On average, they expect HCP's stock price to reach $26.75 in the next year. This suggests that the stock has a possible downside of 10.4%. View Analyst Price Targets for HCP. What is the consensus analysts' recommendation for HCP? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 2 sell ratings, 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for HCP. What are Wall Street analysts saying about HCP stock? Here are some recent quotes from research analysts about HCP stock: 1. According to Zacks Investment Research, "HCP third-quarter 2018 funds from operations (FFO) as adjusted of 44 cents surpassed the Zacks Consensus Estimate. However, the bottom line fell short of the prior-year tally of 48 cents. Further, revenues missed the Zacks Consensus Estimate. Notably, a 6.3% decrease in senior-housing operating portfolio cash net operating income (NOI) marred results. The company has undertaken portfolio-repositioning measures by selling assets in its portfolio. Although such efforts are a strategic fit for the long term, the dilutive impact on earnings in the near term from these dispositions are unavoidable. Further, softness in the seniors housing market fundamentals amid new supply is anticipated to thwart the company’s pricing power. Although shares of HCP have outperformed the industry it belongs to over the past year, the stock has limited upside potential given lack of positive estimate revisions." (11/13/2018) 2. Cantor Fitzgerald analysts commented, "We are initiating coverage of HCP with a $28 price target and a Neutral rating. HCP has risen by 16% over the past three months, along with other large-cap REITs, but it is down 17.5% over the past year, compared with a 14% gain in the 12% decline in the S&P U.S. Healthcare REIT Index. We believe that most of the stock’s relative weakness reflects concern about interest rates, deteriorating fundamentals in senior housing and HCP’s restructuring. With HCP’s restructuring nearly at an end, we expect investors to begin valuing the company more on its fundamentals, which we expect to improve, and to worry less about interest rates. Although we think senior housing could remain slow for awhile, we are enthusiastic about HCP’s strategy to leverage its position in life science and MOB." (8/7/2018) Has HCP been receiving favorable news coverage? News coverage about HCP stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. HCP earned a media sentiment score of 1.9 on InfoTrie's scale. They also assigned news stories about the real estate investment trust a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the stock's share price in the near future. Who are some of HCP's key competitors? Some companies that are related to HCP include CROWN CASTLE In/SH SH (CCI), Prologis (PLD), Public Storage (PSA), Equinix (EQIX), Welltower (WELL), Equity Residential (EQR), AvalonBay Communities (AVB), DIGITAL RLTY TR/SH (DLR), Ventas (VTR), Boston Properties (BXP), Realty Income (O), SBA Communications (SBAC), Weyerhaeuser (WY), Essex Property Trust (ESS) and Host Hotels and Resorts (HST). Who are HCP's key executives? HCP's management team includes the folowing people: Mr. Thomas M. Herzog, Pres, CEO & Director (Age 55)Mr. Peter A. Scott, Exec. VP & CFO (Age 38)Mr. Thomas M. Klaritch, Exec. VP & COO (Age 60)Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 45)Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 41) Who are HCP's major shareholders? HCP's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (16.01%), BlackRock Inc. (9.43%), Cohen & Steers Inc. (3.61%), JPMorgan Chase & Co. (2.87%), Daiwa Securities Group Inc. (1.91%) and Dimensional Fund Advisors LP (1.53%). Company insiders that own HCP stock include Kendall K Young, R Kent Griffin Jr, Scott A Anderson and Thomas Klaritch. View Institutional Ownership Trends for HCP. Which major investors are selling HCP stock? HCP stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, JPMorgan Chase & Co., Morgan Stanley, Russell Investments Group Ltd., Hexavest Inc., Brookfield Asset Management Inc., Mitsubishi UFJ Trust & Banking Corp and Sumitomo Mitsui Asset Management Company LTD. View Insider Buying and Selling for HCP. Which major investors are buying HCP stock? HCP stock was bought by a variety of institutional investors in the last quarter, including Cohen & Steers Inc., Daiwa Securities Group Inc., Cullen Capital Management LLC, Allianz Asset Management GmbH, American Century Companies Inc., Korea Investment CORP, Renaissance Technologies LLC and Vanguard Group Inc.. Company insiders that have bought HCP stock in the last two years include Kendall K Young and R Kent Griffin Jr. View Insider Buying and Selling for HCP. How do I buy shares of HCP? Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is HCP's stock price today? One share of HCP stock can currently be purchased for approximately $29.87. How big of a company is HCP? HCP has a market capitalization of $14.04 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $414.16 million in net income (profit) each year or $1.95 on an earnings per share basis. HCP employs 190 workers across the globe. What is HCP's official website? The official website for HCP is http://www.hcpi.com. How can I contact HCP? HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected] MarketBeat Community Rating for HCP (NYSE HCP)Community Ranking: 1.6 out of 5 ()Outperform Votes: 315 (Vote Outperform)Underperform Votes: 678 (Vote Underperform)Total Votes: 993MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe HCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2018 by MarketBeat.com StaffFeatured Article: Hedge Funds - Risk or Reward?